Zimmermann K C, Bonzon C, Green D R. The machinery of programmed cell death[J]. Pharmacology & Therapeutics, 2001, 92(1): 57-70.
[2]
Langston J W, Ballard P, Tetrud J W, et al. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis[J]. Science, 1983, 219 (4587): 979-980.
[3]
Storch A, Kaftan A, Burkhardt K, et al. 1-Methyl-6,7-dihydroxy-1,2, 3, 4- tetrahydroisoquinoline (salsolinol) is toxic to dopaminergic neuroblastoma SH- SY5Y cells via impairment of cellular energy metabolism[J]. Brain Research, 2000, 855(1): 67-75.
[4]
Sandler M, Carter S B, Hunter K R, et al. Tetrahydroisoquinoline alkaloids: in vivo metabolites of L- DOPA in man[J]. Nature, 1973, 241(5390): 439-443.
[5]
Deng Y, Maruyama W, Dostert P, et al. Determination of the (R)-and (S)- enantiomers of salsolinol and N- methylsalsolinol by use of a chiral high-performance liquid chromatographic column[J]. Journal of Chromatography B: Biomedical Sciences and Applications, 1995, 670 (1): 47-54.
[6]
Naoi M, Maruyama W, Akao Y, et al. Apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopamine neurons[J]. Toxicology, 2000, 153(1-3): 123-141.
[7]
Origitano H, Hannigan J, Collins M A. Rat brain salsolinol and bloodbrain barrier[J]. Brain Research, 1981, 224(2): 446-451.
[8]
Song Y, Feng Y Z, LeBlanc M H, et al. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline passes through the blood-brain barrier of rat brain: An in vivo microdialysis study[J]. Neuroscience Letters, 2006, 395(1): 63-66.
[9]
DengY,MaruyamaW,KawaiM,etal.Assayforthe(R)-and(S)-enantiomers of salsolinols in biological samples and foods with ion- pair highperformance liquid chromatography using 13-cyclodextrin as a chiral mobile phase additive[J]. Journal of Chromatography B: Biomedical Sciences and Applications, 1997, 689(2): 313-320.
[10]
Musshoff F, Schmidt P, Dettmeyer R, et al. Determination of dopamine and dopamine-derived (R)-/(S)-salsolinol and norsalsolinol in various human brain areas using solid- phase extraction and gas chromatography/mass spectrometry[J]. Forensic Science International, 2000, 113(1-3): 359-366.
[11]
Zhu W, Wang D, Zheng J, et al. Effect of (R)-Salsolinol and N-Methyl- (R)- Salsolinol on the balance impairment between dopamine and Acetylcholine in rat brain: Involvement in pathogenesis of Parkinson disease[J]. Clinical Chemistry, 2008, 54(4): 705-712.
[12]
Naoi M, Maruyama W, Dostert P, et al. A novel enzyme nantio-selectively synthesizes (R) salsolinol, a precursor of a dopaminergic neurotoxin, N-methyl (R) salsolinol[J]. Neuroscience Letters, 1996, 212(3): 183- 186.
[13]
RojkovicovaT,MechrefY,StarkeyJA,etal.Quantitativechiral analysis of salsolinol in different brain regions of rats genetically predisposed to alcoholism[J]. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Science, 2008, 863(2): 206-214.
[14]
Chen X, Arshad A, Qing H, et al. Enzymatic condensation of dopamine and acetaldehyde: A salsolinol synthase from rat brain[J]. Bliologia, 2011, 66(6): 1183-1188.
[15]
Chen X, Chen Y, Wu G, et al. Existence and characterization of Salsolinol synthase in neuronal cells and rat brain[J]. Neurochemical Journal, 2013, 7(3): 192-197.
[16]
陈薛钗. 帕金森病相关蛋白Salsolinol合成酶的分离纯化及其酶学性质研究[D]. 北京: 北京理工大学, 2011. Chen Xuechai. Purification and characterization of Salsolinol synthase, a Parkinson's disease related protein[D]. Beijing: Beijing Institute of Technology, 2011.
[17]
刘彤, 李晓东, 王桂玲, 等. 一种高效而经济获得长片段基因突变体的方法[J]. 生命科学研究, 2006, 10(1): 34-38. Liu Tong, Li Xiaodong, Wang guiling, et al. An efficient and economic method of obtaining mutant constructs of large DNA fragment[J]. Life Sciense Research, 2006, 10(1): 34-38.
